JMPWA
PBYI icon

JP Morgan Private Wealth Advisors’s Puma Biotechnology PBYI Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,100
Closed -$208K – 1355
2017
Q4 		$208K Buy
+2,100
New +$235K ﹤0.01% 1176
2014
Q4 		– Sell
-1,820
Closed -$434K – 1129
2014
Q3 		$434K Buy
+1,820
New +$374K 0.01% 736

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PBYI Position: Q1 2018 in Review

JP Morgan Private Wealth Advisors sold out of Puma Biotechnology (PBYI) in Q1 2018, closing a stake of 2,100 shares — an estimated $208K sold.

JP Morgan Private Wealth Advisors first reported a position in PBYI in Q3 2014 and held it in 2 quarters. The position peaked at $434K in Q3 2014. 178 funds tracked by Wall St. Rank hold PBYI as of Q1 2018.

  • JP Morgan Private Wealth Advisors reported no remaining Puma Biotechnology position as of Q1 2018 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 2,100 Puma Biotechnology shares in Q1 2018, an estimated $208K.
  • JP Morgan Private Wealth Advisors first reported a position in Puma Biotechnology in Q3 2014 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Puma Biotechnology position peaked at $434K in Q3 2014.
  • 178 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2018, filed 10 May 2018.